Gainers
- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) rose 22.1% to $0.2050 in pre-market trading. Allena Pharmaceuticals disclosed a new meeting date and new record date for special meeting to approve reverse stock split.
- Aditxt, Inc. (NASDAQ:ADTX) rose 20.9% to $0.2085 in pre-market trading after declining over 11% on Wednesday. Aditxt’s Adimune therapeutic program recently completed a toxicology study indicating a favorable safety profile of ADI-100.
- Theravance Biopharma, Inc. (NASDAQ:TBPH) rose 19.4% to $10.30 in pre-market trading. Theravance Biopharma agreed to sell all of its units in Theravance Respiratory Company, LLC, representing 85% economic interest in the sales-based royalty rights on worldwide net sales of GSK’s TRELEGY ELLIPTA to Royalty Pharma for over $1.5 billion.
- Medicenna Therapeutics Corp. (NASDAQ:MDNA) rose 9.4% to $1.51 in pre-market trading after jumping around 16% on Wednesday.
- Taoping Inc. (NASDAQ:TAOP) rose 9.9% to $1.11 in pre-market trading.
- Scopus BioPharma Inc. (NASDAQ:SCPS) rose 9.6% to $0.4646 in pre-market trading.
- Predictive Oncology Inc. (NASDAQ:POAI) rose 8.3% to $0.45 in pre-market trading.
- Endo International plc (NASDAQ:ENDP) rose 7.8% to $0.4465 in pre-market trading. Endo International is considering bankruptcy filing to restructure its more than $8 billion of debt and several outstanding lawsuits without a deal with opioid plaintiffs, the Wall Street Journal reported, citing people familiar with the matter.
- Exela Technologies, Inc. (NASDAQ:XELA) rose 7.8% to $0.1029 in pre-market trading. Exela Technologies confirmed the receipt of acquisition proposal.
- TransGlobe Energy Corporation (NASDAQ:TGA) rose 7.2% to $3.41 in pre-market trading. VAALCO announced plans to acquire TransGlobe in an all-stock transaction.
